SEARCH

SEARCH BY CITATION

References

  • Aznar, J., Villa, P., Espana, F., Estelles, A., Grancha, S. & Falco, C. (1997) Activated protein C resistance phenotype in patients with anti-phospholipid antibodies. Journal of Laboratory Clinical Medicine, 130, 202208.
  • Cabiedes, J., Cabral, A.R. & Alarcon-Segovia, D. (1995) Clinical manifestations of the anti-phospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta2-glycoprotein-I than with anti-phospholipid antibodies. Journal of Rheumatology, 22, 18991906.
  • Comp, P.C. & Esmon, C.T. (1984) Recurrent venous thromboembolism in patients with a partial deficiency of protein S. New England Journal of Medicine, 311, 15251528.
  • Comp, P.C., Nixon, R.R., Cooper, M.R. & Esmon, C.T. (1984) Familial protein S deficiency is associated with recurrent thrombosis. Journal of Clinical Investigation, 74, 20822088.
  • Cumming, A.M., Tait, R.C., Fildes, S., Yoong, A., Keeney, S. & Hay, C.R. (1995) Development of resistance to activated protein C during pregnancy. British Journal of Haematology, 90, 725727.
  • De Stefano, V., Martinelli, I., Mannucci, P.M., Paciaroni, K., Chiusolo, P., Casorelli, I., Rossi, E. & Leone, G. (1999) The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. New England Journal of Medicine, 341, 801806.DOI: 10.1056/NEJM199909093411104
  • Ehrenforth, S., Radtke, K.P. & Scharrer, I. (1995) Acquired activated protein C-resistance in patients with lupus anticoagulants. Thrombosis and Haemostasis, 74, 797798.
  • Fujimura, H., Kambayash, J., Monden, M., Kato, H. & Miyata, T. (1995) Coagulation factor V Leiden mutation may have a racial background. Thrombosis and Haemostasis, 74, 13811382.
  • Galli, M. & Barbui, T. (1999) Anti-prothrombin antibodies: detection and clinical significance in the anti-phospholipid syndrome. Blood, 93, 21492157.
  • Galli, M., Finazzi, G., Bevers, E.M. & Barbui, T. (1995) Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent anti-phospholipid antibodies. Blood, 86, 617623.
  • Galli, M., Finazzi, G. & Barbui, T. (1997a) Anti-phospholipid antibodies: predictive value of laboratory tests. Thrombosis and Haemostasis, 78, 7578.
  • Galli, M., Beretta, G., Daldossi, M., Bevers, E.M. & Barbui, T. (1997b) Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with anti-phospholipid antibodies. Thrombosis and Haemostasis, 77, 486491.
  • Galli, M., Ruggeri, L. & Barbui, T. (1998) Differential effects of anti-beta2-glycoprotein I and anti-prothrombin antibodies on the anticoagulant activity of activated protein C. Blood, 91, 19992004.
  • Ginsberg, J.S., Wells, P.S., Brill-Edwards, P., Donovan, D., Moffatt, K., Johnston, M., Stevens, P. & Hirsh, J. (1995) Anti-phospholipid antibodies and venous thromboembolism. Blood, 86, 36853691.
  • Greaves, M. (1999) Anti-phospholipid antibodies and thrombosis. Lancet, 353, 13481353.
  • Griffin, J.H., Evatt, B., Zimmerman, T.S., Kleiss, A.J. & Wideman, C. (1981) Deficiency of protein C in congenital thrombotic disease. Journal of Clinical Investigation, 68, 13701373.
  • Haim, N., Lanir, N., Hoffman, R., Haim, A., Tsalik, M. & Brenner, B. (2001) Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism. American Journal of Medicine, 110, 9196.
  • Henkens, C.M., Bom, V.J., Seinen, A.J. & Van Der Meer, J. (1995) Sensitivity to activated protein C; influence of oral contraceptives and sex. Thrombosis and Haemostasis, 73, 402404.
  • Horbach, D.A., Van Oort, E., Derksen, R.H. & De Groot, P.G. (1998) The contribution of anti-prothrombin-antibodies to lupus anticoagulant activity: discrimination between functional and non-functional anti-prothrombin-antibodies. Thrombosis and Haemostasis, 79, 790795.
  • Igarashi, M., Matsuura, E., Igarashi, Y., Nagae, H., Ichikawa, K., Triplett, D.A. & Koike, T. (1996) Human beta2-glycoprotein I as an anticardiolipin cofactor determined using mutants expressed by a baculovirus system. Blood, 87, 32623270.
  • Lane, D.A., Mannucci, P.M., Bauer, K.A., Bertina, R.M., Bochkov, N.P., Boulyjenkov, V., Chandy, M., Dahlback, B., Ginter, E.K., Miletich, J.P., Rosendaal, F.R. & Seligsohn, U. (1996) Inherited thrombophilia: Part 1. Thrombosis and Haemostasis, 76, 651662.
  • Male, C., Mitchell, L., Julian, J., Vegh, P., Joshua, P., Adams, M., David, M. & Andrew, M.E. (2001) Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus. Blood, 97, 844849.
  • Malia, R.G., Kitchen, S., Greaves, M. & Preston, F.E. (1990) Inhibition of activated protein C and its cofactor protein S by anti-phospholipid antibodies. British Journal of Haematology, 76, 101107.
  • Martinelli, I., Bucciarelli, P., Margaglione, M., De Stefano, V., Castaman, G. & Mannucci, P.M. (2000) The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both. British Journal of Haematology, 111, 12231229.DOI: 10.1046/j.1365-2141.2000.02502.x
  • Martinuzzo, M., Forastiero, R., Adamczuk, Y., Cerrato, G. & Carreras, L.O. (1996) Activated protein C resistance in patients with anti-beta 2 glycoprotein I antibodies. Blood Coagulation and Fibrinolysis, 7, 702704.
  • Nojima, J., Kuratsune, H., Suehisa, E., Futsukaichi, Y., Yamanishi, H., Machii, T., Kitani, T., Iwatani, Y. & Kanakura, Y. (2001a) Anti-prothrombin antibodies combined with lupus anti-coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus. British Journal of Haematology, 114, 647654.
  • Nojima, J., Kuratsune, H., Suehisa, E., Futsukaichi, Y., Yamanishi, H., Machii, T., Iwatani, Y. & Kanakura, Y. (2001b) Association between the prevalence of antibodies to beta (2) -glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Clinical Chemistry, 47, 10081015.
  • Nomura, T., Suehisa, E., Kawasaki, T. & Okada, A. (2000) Frequency of protein S deficiency in general Japanese population. Thrombosis Research, 100, 367371.
  • Oosting, J.D., Derksen, R.H., Bobbink, I.W., Hackeng, T.M., Bouma, B.N. & De Groot, P.G. (1993) Anti-phospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? Blood, 81, 26182625.
  • Palosuo, T., Virtamo, J., Haukka, J., Taylor, P.R., Aho, K., Puurunen, M. & Vaarala, O. (1997) High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men – a nested case-control study. Thrombosis and Haemostasis, 78, 11781182.
  • Pengo, V., Biasiolo, A., Brocco, T., Tonetto, S. & Ruffatti, A. (1996) Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies. Thrombosis and Haemostasis, 75, 721724.
  • Picillo, U., De Lucia, D., Palatiello, E., Scuotto, A., Marcialis, M.R., Pezzella, S. & Tirri, G. (1998) Association of primary anti-phospholipid syndrome with inherited activated protein C resistance. Journal of Rheumatology, 25, 12321234.
  • Rosing, J., Tans, G., Nicolaes, G.A., Thomassen, M.C., Van Oerle, R., Van Der Ploeg, P.M., Heijnen, P., Hamulyak, K. & Hemker, H.C. (1997) Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives. British Journal of Haematology, 97, 233238.
  • Roubey, R.A. (1994) Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other ``anti-phospholipid'' autoantibodies. Blood, 84, 28542867.
  • Ruiz-Arguelles, G.J., Garces-Eisele, J., Alarcon-Segovia, D. & Ruiz-Arguelles, A. (1996) Activated protein C resistance phenotype and genotype in patients with primary anti-phospholipid syndrome. Blood Coagulation and Fibrinolysis, 7, 344348.
  • Schulman, S., Svenungsson, E. & Granqvist, S. (1998) Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. American Journal of Medicine, 104, 332338.
  • Shimamoto, M., Yoshimura, T., Kimura, N., Kita, M., Hoshino, N., Motoi, S., Suehisa, E., Nishimura, K., Hayashi, C. & Miyai, K. (1988) Protein C in human plasma determined by homogeneous enzyme immunoassay with use of a centrifugal analyzer. Clinical Chemistry, 34, 18341838.
  • Simioni, P., Prandoni, P., Zanon, E., Saracino, M.A., Scudeller, A., Villalta, S., Scarano, L., Girolami, B., Benedetti, L. & Girolami, A. (1996) Deep venous thrombosis and lupus anticoagulant. A case-control study. Thrombosis and Haemostasis, 76, 187189.
  • Suehisa, E., Nomura, T., Kawasaki, T. & Kanakura, Y. (2001) Frequency of natural coagulation inhibitor (anti-thrombin III, protein C and protein S) deficiencies in Japanese patients with spontaneous deep vein thrombosis. Blood Coagulation and Fibrinolysis, 12, 9599.DOI: 10.1097/00001721-200103000-00002
  • Wahl, D.G., Guillemin, F., De Maistre, E., Perret, C., Lecompte, T. & Thibaut, G. (1997) Risk for venous thrombosis related to anti-phospholipid antibodies in systemic lupus erythematosus: a meta-analysis. Lupus, 6, 467473.
  • Zanon, E., Prandoni, P., Vianello, F., Saggiorato, G., Carraro, G., Bagatella, P. & Girolami, A. (1999) Anti-beta2-glycoprotein I antibodies in patients with acute venous thromboembolism: prevalence and association with recurrent thromboembolism. Thrombosis Research, 96, 269274.DOI: 10.1016/S0049-3848(99)00105-X
  • Zivelin, A., Gitel, S., Griffin, J.H., Xu, X., Fernandez, J.A., Martinowitz, U., Cohen, Y., Halkin, H., Seligsohn, U. & Inbal, A.(1999) Extensive venous and arterial thrombosis associatedwith an inhibitor to activated protein C. Blood, 94, 895901.